11:15 AM EDT, 09/04/2024 (MT Newswires) -- Hepion Pharmaceuticals ( HEPA ) and Pharma Two B said Wednesday that a registration statement has been filed with the Securities and Exchange Commission for their planned merger transaction.

The companies said the registration statement, which was filed by Pharma Two B, is not yet effective and the information provided in the filing related to their proposed transaction remains subject to change.

The boards of Hepion and Pharma Two B have approved the transaction and the companies expect to close the merger in Q4. Closing conditions include the listing of Pharma Two B's common shares on Nasdaq and approvals from regulators and the companies' shareholders, according to the joint statement.

Following closing, the combined company will operate under the name Pharma Two B, the companies added.

Price: 0.77, Change: +0.02, Percent Change: +2.23